Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Projects

Terapia basada en microRNAs para Neuroblastomas de alto riesgo

IP: Miguel Segura Ginard
Collaborators: Aroa Soriano Fernández, Josep Roma Castanyer
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC-JB-2012-01
Duration: 07/02/2013 - 07/02/2015

Functional role of micro RNA in high-risk neuroblastomas

IP: Miguel Segura Ginard
Collaborators: Aroa Soriano Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 121500
Reference: CP11/00052
Duration: 01/01/2012 - 30/04/2015

Related news

Dr. Gabriela Guillén receives the award for best presentation at SECP

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

Biomarkers gain prominence in paediatric cancer clinical trials

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.